Our results suggest that loss of PTEN expression is associated with the aggressive capacity of colorectal cancer and that understanding the biologic mechanisms responsible for regulation of PTEN expression may enable better translational treatment of colorectal cancer patients. The gene discussed is PTEN; the disease is colorectal cancer.